Document Detail


WIN 55212-2 impairs contextual fear conditioning through the activation of CB1 cannabinoid receptors.
MedLine Citation:
PMID:  16406322     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The memory deficits induced by cannabinoid agonists have been found in several behavioral paradigms. Nevertheless, there is evidence that not all types of memory are impaired after cannabinoid administration. The aim of this study was to investigate whether the cannabinoid agonist WIN 55212-2 (WIN) is able to influence the acquisition of fear conditioning using tone and contextual versions. For tone-fear conditioning, male Wistar rats were placed in the conditioning chamber and after 3 min, a sound (CS) was presented for 10s that terminated with a 1-s electric footshock (1.5 mA). For contextual-fear conditioning, a similar procedure was used but no sound was presented. Twenty-four hours after, the animals were re-exposed to the respective CS (tone or conditioning chamber) and the freezing behavior was registered. A subsequent experiment investigated a possible state-dependent effect of WIN by administering WIN or control solution 30 min before conditioning and before testing. WIN (2.5 and 5.0 mg/kg) administered i.p. 30 min before impaired contextual fear conditioning but did not modify the freezing behavior elicited by tone presentation. These animals did not show any state-dependent effects of WIN. Further, the impaired contextual conditioning was prevented by preadministration of SR141716A (1.0 mg/kg, i.p.) or SR147778 (1.0 mg/kg, i.p.), selective cannabinoid CB1 receptor antagonists. The present findings highlight that cannabinoid agonists effects are selective for the hippocampus-dependent aversive memories in rats. This effect appears to be related to the activation of CB1 cannabinoid receptors and confirms that cannabinoids might provide a novel approach for the treatment of unpleasant memories.
Authors:
Fabrício Alano Pamplona; Reinaldo Naoto Takahashi
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, Non-U.S. Gov't     Date:  2006-01-06
Journal Detail:
Title:  Neuroscience letters     Volume:  397     ISSN:  0304-3940     ISO Abbreviation:  Neurosci. Lett.     Publication Date:    2006 Apr 10-17
Date Detail:
Created Date:  2006-03-08     Completed Date:  2006-05-25     Revised Date:  2012-05-30    
Medline Journal Info:
Nlm Unique ID:  7600130     Medline TA:  Neurosci Lett     Country:  Ireland    
Other Details:
Languages:  eng     Pagination:  88-92     Citation Subset:  IM    
Affiliation:
Departamento de Farmacologia CCB-UFSC, Centro de Ciências Biológicas, Universidade Federal de Santa Catarina, Campus Universitário Trindade, 88049-900 Florianópolis, SC, Brazil.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Analgesics / pharmacology*
Analysis of Variance
Animals
Behavior, Animal
Benzoxazines
Conditioning (Psychology) / drug effects*
Dose-Response Relationship, Drug
Fear*
Freezing Reaction, Cataleptic / drug effects
Male
Morpholines / pharmacology*
Naphthalenes / pharmacology*
Piperidines / pharmacology
Pyrazoles / pharmacology
Rats
Rats, Wistar
Receptor, Cannabinoid, CB1 / antagonists & inhibitors,  physiology*
Chemical
Reg. No./Substance:
0/Analgesics; 0/Benzoxazines; 0/Morpholines; 0/Naphthalenes; 0/Piperidines; 0/Pyrazoles; 0/Receptor, Cannabinoid, CB1; 0/surinabant; 134959-51-6/Win 55212-2

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Candidate gene analysis of the succinic semialdehyde dehydrogenase gene (ALDH5A1) in patients with i...
Next Document:  Epidermal growth factor (EGF) expression in lateral line system and in taste buds of adult zebrafish...